Evolus, Inc. reported that President and Chief Executive Officer David Moatazedi sold 116,720 shares of common stock on March 17, 2026, receiving approximately $570,562 in aggregate proceeds. The share prices for the sale ranged between $4.8874 and $5.015 per share, according to a Form 4 filing submitted to the Securities and Exchange Commission.
The filing specifies that the disposition was performed to cover tax-withholding obligations arising from the vesting and settlement of performance stock units (PSUs) and restricted stock unit awards. The sales were executed under a pre-arranged Rule 10b5-1 trading plan, the filing shows.
One day earlier, on March 16, 2026, Moatazedi received 67,489 shares of Evolus common stock upon the vesting of performance restricted stock units. That vesting event was recorded at a per-share price of $0, producing a total reported value of $0 for the issued shares.
As a result of these movements, Moatazedi now directly holds 618,369 shares of Evolus, Inc.
The insider sale takes place while Evolus shares are trading at $4.84, a level that represents a 64% decline over the past 12 months and sits close to the company’s 52-week low of $4.09. Analysis from InvestingPro cited in company reporting places a Fair Value for the stock at $6.02.
Financially, Evolus carries a market capitalization of $313 million and remains unprofitable, with earnings per share of -$0.80 over the last twelve months. The filing notes that two analysts have recently revised their earnings estimates upward.
In other corporate developments, Evolus disclosed fourth-quarter 2025 results in which reported revenue was $90.3 million versus a consensus projection of $90.75 million, a modest revenue shortfall relative to expectations. The company also made a board-class adjustment: Vikram Malik was reclassified from a Class III director to a Class II director to preserve board-class balance after the departure of Simone Blank.
Company filings and the recent disclosures together outline the proximate drivers behind the reported insider transaction and provide context on Evolus’ current market position and governance adjustments. The company’s reported financial performance and board reclassification are noted alongside the CEO’s tax-related sale carried out within an established trading plan.